tiprankstipranks
Danya Cebus Ltd (IL:DNYA)
TASE:DNYA
Israel Market
Want to see IL:DNYA full AI Analyst Report?

Danya Cebus (DNYA) AI Stock Analysis

0 Followers

Top Page

IL:DNYA

Danya Cebus

(TASE:DNYA)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - Gpt-5.6Sol)
Rating:54Neutral
Price Target:
9,996.00
▼(-7.10% Downside)
Action:Reiterated
Date:08/19/26
Overall score is driven by mixed financial performance (healthy balance sheet but pressured near-term revenue/margins and volatile cash flow) and weak technicals (broad downtrend with bearish momentum). Valuation provides partial support via a solid dividend yield and a moderate P/E.
Positive Factors
Healthy Balance Sheet
Moderate leverage and a sizable equity base provide financial resilience for a project-driven contractor. This supports continued bidding, execution and investment capacity, although debt growth must be monitored if operating conditions weaken.
Negative Factors
TTM Revenue Contraction
The sharp trailing-period revenue decline signals weaker project activity or execution volume and creates operating deleverage risk. If sustained, lower scale could pressure profitability, backlog conversion and the company’s ability to absorb fixed costs.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthy Balance Sheet
Moderate leverage and a sizable equity base provide financial resilience for a project-driven contractor. This supports continued bidding, execution and investment capacity, although debt growth must be monitored if operating conditions weaken.
Read all positive factors

Danya Cebus (DNYA) vs. iShares MSCI Israel ETF (EIS)

Danya Cebus Business Overview & Revenue Model

Company Description
Danya Cebus Ltd. is a construction company involved in the planning and execution of diverse projects, both in Israel and globally. Its portfolio encompasses a broad spectrum of construction, including significant infrastructure initiatives like r...
How the Company Makes Money
null...

Danya Cebus Financial Statement Overview

Summary
Mixed fundamentals. The balance sheet is relatively healthy (moderate leverage and strong ROE), but the TTM revenue drop and margin compression are notable near-term risks. Cash flow is volatile, including negative operating/free cash flow in 2025 and weaker free-cash-flow consistency overall.
Income Statement
56
Neutral
Balance Sheet
72
Positive
Cash Flow
43
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.44B6.51B6.03B5.42B4.49B4.06B
Gross Profit270.86M265.70M253.00M279.24M278.88M198.13M
EBITDA331.81M333.48M316.25M336.11M300.77M228.94M
Net Income161.33M168.56M173.63M196.05M175.31M213.31M
Balance Sheet
Total Assets3.71B3.27B2.74B2.49B2.30B2.26B
Cash, Cash Equivalents and Short-Term Investments464.80M385.48M729.72M648.08M549.29M481.64M
Total Debt341.09M157.83M130.03M109.97M84.10M93.21M
Total Liabilities2.83B2.36B1.97B1.73B1.59B1.63B
Stockholders Equity883.20M908.49M766.99M759.21M704.90M629.45M
Cash Flow
Free Cash Flow84.08M-188.94M188.90M229.24M90.21M177.87M
Operating Cash Flow162.24M-109.27M255.46M269.56M155.64M203.69M
Investing Cash Flow-353.07M-157.43M67.62M96.41M78.25M-72.46M
Financing Cash Flow148.65M-93.75M-225.35M-188.53M-139.54M-130.10M

Danya Cebus Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
58
Neutral
₪8.32B7.000.81%14.01%-10.85%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
₪3.54B21.835.00%-2.12%-9.77%
47
Neutral
₪4.29B58.2940.30%-5.49%
45
Neutral
₪15.42B55.810.48%18.29%46.66%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:DNYA
Danya Cebus
10,840.00
-1,715.81
-13.67%
IL:SKBN
Shikun & Binui
1,790.00
315.00
21.36%
IL:ELTR
Electra
11,410.00
1,564.61
15.89%
IL:LUZN
Luzon Group
448.10
158.96
54.98%
IL:SPEN
Shapir Eng
4,310.00
1,679.77
63.86%
IL:RMON
Rimon
11,740.00
4,927.00
72.32%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2026